Aktuellt
SENASTE
The recorded sales growth is 0% in local currency due to an extended headwind for the Genetics business even if this was better than expected, and a softer quarter for Americas and EMEA. The OPEX level is contained, and we expect an adverse share price reaction and a negative consensus revision due to Vitrolife’s Q1.
LÄS MER
